Lonza’s new drug product manufacturing line in Switzerland goes live

By Jane Byrne

- Last updated on GMT

Lonza's facility in Visp, Switzerland © Lonza
Lonza's facility in Visp, Switzerland © Lonza

Related tags Lonza CDMO Visp Drug substances

Swiss CDMO Lonza has increased capacity and capabilities at its Visp, Switzerland site, with the completion of a new line for cGMP clinical and commercial drug product manufacturing.

The line is fully operational, and the first customer batches will be filled in April 2023, said the Basel headquartered contract development and manufacturing organization.

The new line will support customers with a range of drug product manufacturing needs for both clinical and commercial supply. Set in a 1,200 sq. m cGMP facility, it includes a liquid and lyophilized vial filling isolator line for multiple modalities.

The asset complements recent expansions at the Visp site, including in bioconjugation, mammalian manufacturing and microbial development.

From drug substance to drug product

Lonza said these developments support its long-term growth strategy to build capacity in areas of high customer demand, and its ambition to provide flexible end-to-end solutions for customers at one location – from drug substance to drug product.

“With demand for drug product manufacturing continuing to increase, this new cGMP clinical and commercial line in Visp launches at a crucial time for our customers and market. It also strengthens our DPS capabilities,” said Peter Droc, head of drug product services (DPS) at Lonza.

The completion of the line in Visp follows the recent ground-breaking of a new facility in Stein, also in Switzerland, which will be dedicated to large-scale commercial drug product manufacturing and is being delivered through an investment of CHF500m (US$545.9m). 

Related topics Bio Developments Facilities

Related news

Show more

Related product

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Related suppliers